In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...

The workshop will train healthcare providers on the HEARTS clinical pathway, including guidance on medication ... “It’s a ...

The European approval comes months after the FDA’s approval of the first-of-its-kind treatment for pulmonary arterial ...

The FDA cleared DeepWell DTx's software development kit with indications for stress reduction and hypertension.

Mosliciguat, an inhaled once-daily PH medication, can reduce the resistance against blood flow in lung blood vessels, a Phase ...

Inflammation and genetic mutations can drive cardiovascular complications in patients with myeloproliferative neoplasms, which include disorders such as polycythemia vera, essential thrombocythemia, ...

Liddle syndrome is an autosomal dominant disorder caused by hyperactivity of the amiloride-sensitive sodium channel (ENaC) of the principal cell of the cortical collecting tubule. In 1963, Liddle ...

Combining radium-223 with enzalutamide offered a survival benefit in metastatic castration-resistant prostate cancer, but experts questioned its relevance in a shifting treatment landscape.

Corcept is a profitable biotech company with significant potential for growth, focusing on treating Cushing's Syndrome and ...

This is needed, and please treat hypertension," Fizazi stated ... fracture risk in men with asymptomatic mCRPC as compared with the androgen receptor pathway inhibitor alone. In the era prior to ...

The following is a summary of “Prevention of Heart Failure in Hypertension – the Role of Coronary Heart Disease Events ...

Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on Purple Biotech (PPBT – Research Report). The associated price ...